A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, recently presented data demonstrating ...

Q4 2024 Earnings Call Transcript March 11, 2025 Operator: Welcome to the SIGA Business Update Call. Before we turn the call ...

But when the pain got too much the man decided to go to the infectious diseases clinic at the Alfred to get the Tecovirimat TPOXX antiviral treatment. However when he presented to the emergency ...

It started as a single painful spot on his nose. But what started as an innocent blemish quickly turned into a searing wound.

This article covers precautions such as vaccination and isolation, available therapies like tecovirimat, and guidelines on fetal monitoring. Conclusion: Finally, this paper proposes an integrated ...

This article covers precautions such as vaccination and isolation, available therapies like tecovirimat, and guidelines on fetal monitoring. Conclusion: Finally, this paper proposes an integrated ...

Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...